Clinical Outcomes Mandible: Buffered 1% vs. Non-Buffered 1% Lidocaine
Clinical trial NCT03127943 · COMPLETED
Trial details
- NCT number
- NCT03127943
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-01
- Primary completion
- 2018-04-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.